| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |